C060P: Pateclizumab Biosimilar (Research Grade), Anti-human Lymphotoxin Alpha (LT-α) Monoclonal Antibody
Recombinant Humanized IgG1 kappa Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade pateclizumab biosimilar specifically binds to the human lymphotoxin alpha (LT-α).
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by pateclizumab.C065P: Volociximab Biosimilar (Research Grade), Anti-human Integrin α5β1 Monoclonal Antibody
Recombinant Humanized IgG4 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade volociximab biosimilar specifically binds to the human integrin α5β1.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by volociximab.C067P: Zalutumumab Biosimilar (Research Grade), Anti-human Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The research grade zalutumumab biosimilar specifically binds to the human epidermal growth factor receptor (EGFR).
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by zalutumumab.C066P: Toralizumab Biosimilar (Research Grade), Anti-human CD40L Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade toralizumab biosimilar specifically binds to the human CD40L / CD154 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by toralizumab.C064P: Satumomab Biosimilar (Research Grade), Anti-human TAG-72 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade satumomab biosimilar specifically binds to the human tumor-associated glycoprotein TAG-72.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by satumomab.C063P: Ruplizumab Biosimilar (Research Grade), Anti-human CD40L Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade ruplizumab biosimilar specifically binds to the human CD40L.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by ruplizumab.C104P: Dupilumab Biosimilar, IL4R alpha Monoclonal Antibody
Recombinant fully human IgG4 monoclonal antibody.
Specificity/Sensitivity: The monoclonal antibody dupilumab biosimilar specifically binds to the human IL4R alpha.
Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by dupilumab.C106P: Ifinatamab Biosimilar, B7-H3 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The research grade ifinatamab biosimilar specifically binds to the human B7-H3 (CD276) protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by ifinatamab.C052P: Polatuzumab Biosimilar, CD79B Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The research grade polatuzumab biosimilar specifically binds to the CD79B protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by polatuzumab.C109P: Tusamitamab Biosimilar, CEACAM5 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The research grade tusamitamab biosimilar specifically binds to the CEACAM5 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by tusamitamab.